{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:11:52Z","timestamp":1790907112785,"version":"4.1.0"},"reference-count":22,"publisher":"BMJ","issue":"e3","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"JSPS"},{"DOI":"10.13039\/100020685","name":"Japan Hospice Palliative Care Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020685","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["JP20K16567"],"award-info":[{"award-number":["JP20K16567"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2023,3,23]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The prognostic factors in patients with malignancy-related ascites (MA) have been poorly investigated. This study aimed to evaluate both the prognostic impact of MA on terminally ill patients with cancer and the prognostic factors in those with MA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a post hoc analysis of a multicentre, prospective cohort study. Patients with advanced cancer admitted to palliative care units at 23 institutions and aged\u226518 years were enrolled between January and December 2017. Overall survival (OS) was compared according to MA. A multivariate analysis was conducted to explore prognostic factors in patients with MA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 1896 eligible patients, gastrointestinal and hepatobiliary pancreatic cancers accounted for 42.5%. 568 (30.0%) of the total had MA. Patients with MA had significantly shorter OS than those without MA (median, 14 vs 22 days, respectively; HR, 1.55; 95% CI, 1.39 to 1.72; p&lt;0.01). A multivariate analysis showed that MA was a poor prognostic factor (HR, 1.30; 95%\u2009CI, 1.13 to 1.50; p&lt;0.01) and that among patients with MA, significant poor prognostic factors were liver metastasis, moderately to severely reduced oral intake, delirium, oedema, gastric cancer, high serum creatinine, high serum C reactive protein, high serum total bilirubin, dyspnoea and fatigue, while significant good prognostic factors were female sex, good performance status, high serum albumin and colorectal cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MA had a negative impact on survival in terminally ill patients with cancer. A multivariate analysis revealed several prognostic factors in patients with terminal cancer and MA.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2023-004286","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T17:22:45Z","timestamp":1682011365000},"page":"e1292-e1299","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Malignancy-related ascites in palliative care units: prognostic factor analysis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2898-4860","authenticated-orcid":false,"given":"Toru","family":"Kadono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Ishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naosuke","family":"Yokomichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isseki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-3487","authenticated-orcid":false,"given":"Yutaka","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7031-7279","authenticated-orcid":false,"given":"Tomofumi","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-9881","authenticated-orcid":false,"given":"Jun","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"2024051713542284000_13.e3.e1292.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402033300508"},{"key":"2024051713542284000_13.e3.e1292.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080521"},{"key":"2024051713542284000_13.e3.e1292.3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl499"},{"key":"2024051713542284000_13.e3.e1292.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2004.01.035"},{"key":"2024051713542284000_13.e3.e1292.5","first-page":"474","article-title":"Malignant ascites: demographics, therapeutic efficacy and predictors of survival","volume":"6","author":"Mackey","year":"1996","journal-title":"Can J Oncol"},{"key":"2024051713542284000_13.e3.e1292.6","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198606000-00009"},{"key":"2024051713542284000_13.e3.e1292.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220869","article-title":"A survey of practice in management of malignancy-related ascites in japan","volume":"14","author":"Kanai","year":"2019","journal-title":"PLoS One"},{"key":"2024051713542284000_13.e3.e1292.8","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-012-0396-6"},{"key":"2024051713542284000_13.e3.e1292.9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122926","article-title":"Tunnelled peritoneal catheter for malignant ascites-an open-label, prospective, observational trial","volume":"13","author":"Petzold","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2024051713542284000_13.e3.e1292.10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1177\/000313481107700830","article-title":"Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post leveen era","volume":"77","author":"White","year":"2011","journal-title":"Am Surg"},{"issue":"Supplement","key":"2024051713542284000_13.e3.e1292.11","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.4103\/jcrt.JCRT_606_18","article-title":"Therapeutic results of Denver percutaneous peritoneovenous shunt in cancer patients with malignant ascites","volume":"16","author":"Tamagawa","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"2024051713542284000_13.e3.e1292.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00145-6"},{"key":"2024051713542284000_13.e3.e1292.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00146-8"},{"key":"2024051713542284000_13.e3.e1292.14","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050242"},{"key":"2024051713542284000_13.e3.e1292.15","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/29.3.156"},{"key":"2024051713542284000_13.e3.e1292.16","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0397"},{"key":"2024051713542284000_13.e3.e1292.17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpainsymman.2020.07.031","article-title":"Communication and behavior of palliative care physicians of patients with cancer near end of life in three East Asian countries","volume":"61","author":"Yamaguchi","year":"2021","journal-title":"Journal of Pain and Symptom Management"},{"key":"2024051713542284000_13.e3.e1292.18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jjco\/hyy203","article-title":"Validation of the integrated palliative care outcome scale (IPOS) \u2013 Japanese version","volume":"49","author":"Sakurai","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"2024051713542284000_13.e3.e1292.19","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1007\/s00520-022-07057-8","article-title":"Effect of paracentesis on the survival of patients with terminal cancer and ascites: a propensity score-weighted analysis of the east asian collaborative cross-cultural study to elucidate the dying process","volume":"30","author":"Masuda","year":"2022","journal-title":"Support Care Cancer"},{"key":"2024051713542284000_13.e3.e1292.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4920","article-title":"Development of prognosis in palliative care study (pips) predictor models to improve prognostication in advanced cancer: prospective cohort study","volume":"343","author":"Gwilliam","year":"2011","journal-title":"BMJ"},{"key":"2024051713542284000_13.e3.e1292.21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jpainsymman.2014.10.010","article-title":"Independent validation of the modified prognosis palliative care study predictor models in three palliative care settings","volume":"49","author":"Baba","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"2024051713542284000_13.e3.e1292.22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4082\/kjfm.2014.35.6.283","article-title":"Validation of the prognosis in palliative care study predictor models in terminal cancer patients","volume":"35","author":"Kim","year":"2014","journal-title":"Korean J Fam Med"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2023-004286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:52:53Z","timestamp":1715989973000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2023-004286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":22,"journal-issue":{"issue":"e3","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/spcare-2023-004286"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2023-004286","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]}}}